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Specialized voltage-gated calcium channels in the Cav2 channel class (such as Cav2.2, 
N-type) mediate neurotransmitter release from presynaptic nerve terminals. Cav2.2 channels 
are exquisitely sensitive to inhibition by G protein-coupled receptors. The ubiquitous form of 
G protein modulation is a fast, membrane delimited, voltage-dependent form of regulation, 
which is relieved by strong depolarizations. LCav2, an invertebrate homolog from the 
pulmonate snail Lymnaea stagnalis, serves a similar function as a mediator of transmitter 
release in the nervous system. To examine the G protein modulation capacity in invertebrates, 
LCav2 was cloned to a bicistronic expression vector pIRES2-EGFP and expressed in 
HEK293T cells. Although LCav2 was almost indistinguishable from mammalian Cav2.2 in 
biophysical characteristics observed in vitro, snail LCav2 channel lacked the property of 
voltage dependent G protein modulation. The structural elements essential for the voltage 
sensitivity to G protein modulation were explored by swapping the N-terminus and I-II linker 
regions of rCav2.2 channels into LCav2 calcium channels. Functional comparisons were also 
made using both mammalian and invertebrate homologs of G protein beta subunits, Gβ1. 
Neither the N-terminus or I-II linker region of Cav2.2 alone, nor the invertebrate G protein 
beta subunit was sufficient for voltage-dependent G protein modulation. Further analyses 
using chimeric channels and G protein subunits will be required to find the minimal structural 
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Chapter 1 Introduction 
1.1 Voltage Gated Calcium Channels and Neurotransmitter release 
Neurotransmitters are the information carriers and signal transducers for neurons. 
Neurotransmitters bind to diverse postsynaptic receptors and then mediate multiple processes 
such as emotions, learning and behaviors (Hyman, 2005). For example, γ-aminobutyric acid 
(GABA) and serotonin (5-HT) have been reported to be involved in nociceptive modulation 
(Fields et al., 1991) while glutamate, dopamine, as well as GABA impacts learning and 
memory in behavioral tasks (Myhrer, 2003). The mechanics of synaptic transmission between 
neurons has been widely studied (Figure 1): When a propagating nerve action potential 
arrives at the presynaptic terminal, the change of membrane potential causes the opening of 
Voltage Gated Calcium Channels (VGCC) in presynaptic membranes, which leads to the 
influx of calcium ions. The rise in calcium is sensed by special calcium binding proteins 
catalyzing the fusion of neurotransmitter vesicles with the presynaptic membrane, a process 
that leads to the release of neurotransmitter into the synapse cleft. After diffusing across the 
synapse to the post-synaptic neurons, neurotransmitters bind to their specific receptors 
activating downstream pathways (Hyman, 2005; Ziv and Garner, 2004). Concerning their 
essential roles, the structure and modulation of VGCC are the focus of many researchers. 
 
1.2 Voltage Gated Calcium Channels 
Calcium ions are important signal molecules and they play a critical role in modulating 
cell functions such as synaptic development, muscular contraction and setting the firing 
frequency of neurons (Catterall, 2000; Zamponi, 2005). Voltage-gated calcium channels 
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(VGCC) are membrane-spanning proteins that mediate calcium ion entry and respond to 
membrane depolarization. Channel subtypes were initially identified based on the sensitivity 
to different drugs and the distinct biophysical characteristics of currents with the help of 
specific blockers and agonists. The structure and function of calcium channels were better 
understood after the individual calcium channel genes were cloned (Dolphin, 2006). 
 
1.2.1 VGCC classification 
Ten mammalian genes of α1 subunit, the major pore forming subunit for VGCC, have 
been isolated, all displaying specialized functions and distributions. Based on the cDNA 
sequence similarity and amino acid conservation, VGCC could be divided into three major 
families: Cav1 channels (L-Type), Cav2 channels including Cav2.1 (N-type), Cav2.2 
(P/Q-type), and Cav2.3 (R-type), and Cav3 (T-type). While the first two classes belonging to 
HVA (High Voltage Activated) calcium channels which are activated above the resting 
potential, Cav3 belongs to LVA (Low Voltage Activated) calcium channels active at rest 
(Dolphin, 2006; Ertel et al., 2000). As shown in Table 1, different calcium channels are 
associated with distinct biological functions, tissue distribution and pharmacological 
properties. 
Among the multiple VGCC genes, only the Cav2 family is considered to be directly 
involved in neurotransmitter release. Blockade of VGCC with specific antagonists such as 
ω-conotoxin GVIA (ω-CTX) or spider toxin AgaIVA, will inhibit N- (Cav2.2) and P/Q-type 
(Cav2.1) calcium channels respectively, and will block synaptic transmission, suggestive of a 
direct role of these calcium channel subtypes with the synaptic release of neurotransmitter 
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(Takahashi and Momiyama, 1993; Wheeler et al., 1994). When synthesized peptide was 
injected into presynaptic neurons to disrupt the interaction between N-type (Cav2.2) calcium 
channel and synaptic core complex, the neurotransmitter release between paired synapses 
recorded by EPSPs (Excitatory Postsynaptic Potentials) was also inhibited, indicating that 
N-type calcium channels were required for neurotransmission (Mochida et al., 1996). 
Immunocytochemistry work indicated that both Cav2.1 and Cav2.2 channels were primarily 
clustered in synaptic terminals where they participated in the release of neurotransmitter at 
active zones (Westenbroek et al., 1992; Westenbroek et al., 1995).  
 
1.2.2 VGCC structure 
HVA Calcium Channels form a heteroligomeric complex composed of four subunits 
α1, α2, δ, β subunits and sometimes a γ subunit (Figure 2), while the primary pore forming α1 
subunit contains the minimal machinery for a functional channel (Arikkath and Campbell, 
2003).   
The core α1 subunit, coding approximately 2000 amino acids (~212 kD), is composed of 
four repeat membrane spanning domains, each consisting of six transmembrane segments 
(labeled S1 through S6). Cytoplasmic linkers (I-II, II-III and III-IV linkers) connecting these 
four domains and the cytoplasmic N- and C-terminals are focal points for many specific 
intracellular protein interactions. The α1 subunit is also the primary pore forming subunit 
mediating the calcium entry, containing the voltage sensor and many of the drug binding sites. 
For example, the fourth helix of each domain is highly positive charged to sense the 
membrane electric field and homologous glutamate residues in all four domains of the pore 
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region (in the reentrant extracellular loop connecting 5th and 6th helices) are involved in 
calcium ion selection. (Catterall, 2000; McCleskey, 1994; Tedford and Zamponi, 2006) 
The ~55kD β subunit is the best understood auxiliary subunit. Vertebrates express four β 
subunit genes, each bearing multiple splicing isoforms. Although several isoforms could 
associate with the plasma membrane, the β subunit is a hydrophilic, intracellular protein 
without any transmembrane segments. The beta subunit associates with calcium channel α1 
subunits through the Alpha Interacting Domain (AID). AID binds to a deep hydrophobic 
groove in the guanylate kinase domain of beta subunits. Coexpression of the β subunit could 
modulate a lot of functions of VGCC including upregulating current densities and modifying 
current kinetics (Arikkath and Campbell, 2003; Catterall, 2000; Tedford and Zamponi, 2006). 
It was proposed that the  β subunit promotes membrane expression of calcium channels by 
masking the endoplasmic reticulum retention signal in α1 subunit (Bichet et al., 2000). The β 
subunit may also affect the G protein inhibition of calcium channels by disrupting their 
association (Campbell et al., 1995).   
α2−δ subunits, around 170kD in total, are two peptides encoded by the same gene and 
connected by disulfide bonds. They are extensively glycosylated. α2 subunit is located 
extracellularly anchored by a δ subunit. Four vertebrate α2−δ subunits genes have been 
identified. The coexpression of α2−δ subunits could enhance the peak current amplitude and 
alter the channel pharmacology (Arikkath and Campbell, 2003; Catterall, 2000; Tedford and 
Zamponi, 2006). Extracellular domains of α2−δ subunits have been shown to be responsible 
for increasing the drug binding affinity for the Cav1.2 calcium channel (Gurnett et al., 1997). 
Τhe  γ subunit was thought to be only associated with skeletal VGCC but several recent 
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study revealed it might exist in the nervous system as well (Letts et al., 1998). However, 
compared to β and α2−δ subunits which are necessary for VGCC expression and function, γ 





















Figure 1: Physical coupling between calcium channel and synaptic vesicle docking/fusion 
apparatus. A high intracellular rise in calcium ion concentration is required for 
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  Summarized from (Catterall, 2000; Ertel et al., 2000; Newcomb et al., 1998; Tanaka and 








Figure 2: The predicted membrane topology, subunit interactions and structure domains of the 

































1.3 G proteins 
G proteins are GTP binding proteins, belonging to the GTPase superfamily which serves 
to transduce cell-surface receptor signaling to cytoplasmic effectors. The G protein mediated 
signal pathway is a major mechanism to transduce the extracellular signals into intracellular 
responses. G proteins form a heterotrimeric αβγ complex composed of an α subunit of 39-46 
kDa, a β subunit of 37kDa and a γ subunit ~8 kDa, each composed of a variety of genes. At 
rest, GDP is bound to the α subunit. Once activated, the GDP is replaced by GTP, which leads 
to the disassociation of βγ subunits. Both α subunit and βγ subunits can trigger downstream 
pathways. Signaling is terminated when the α subunit hydrolyzes GTP to GDP, and the βγ and 
α subunits reform a heterotrimeric complex.(Hepler and Gilman, 1992)   
 According to the structural homology and target specificity of α subunit, G proteins are 
grouped into 4 main families: Gs, Gi, Gq and G12. Among them, the Gi family, which 
down-regulates the adenylate cyclase, can be inhibited by pertussis toxin (PTX) (Hepler and 
Gilman, 1992). Although Gα subunit determines the basic G protein type and widely 
regulates different protein targets, accumulating evidence indicates multiple roles of Gβγ 
subunits, including modulating ion channels and activating enzymes/secondary signaling 
molecules. Six G protein β and twelve Gγ genes have been identified in mammals. βγ 
subunits form a tight complex which can only be separated by extreme conditions, such as 
denaturation. The multiple combinations of different G protein subunits guarantee diversity 
and specificity in fine-tuning physiological mechanisms (Clapham and Neer, 1997; Hepler 
and Gilman, 1992; Wettschureck and Offermanns, 2005). 
Extracellular signals including a large number of hormones, neurotransmitters, 
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chemokines, and sensory stimuli can activate the G protein signal pathway by binding to 
GPCR (G Protein Coupled Receptors), such as the β-adrenergic receptor, opioid receptor and 
dopamine receptor, which are key controllers of physiological processes. GPCR are 
ubiquitous in metazoans and share a common structure of seven transmembrane segments, 
with an extracellular amino terminus and an intracellular carboxy terminus. There is little 
sequence similarity between different GPCR families, which may utilize distinct structures 
and mechanisms to activate specific G proteins (Bouvier, 2001; Dolphin et al., 1999). 
Through GPCR, G proteins mediate signaling of diverse physiological functions, such as 
cardiac regulation through β-adrenergic receptor and muscarinic receptor by sympathetic and 
parasympathetic systems, insulin secretion inhibition through the α2-adrenergic receptor in 
pancreatic β cells, and inhibitory neurotransmitter release through GABAB receptors 
(Wettschureck and Offermanns, 2005). 
  
1.4 G protein modulation of neuronal calcium channels 
Voltage Gated Calcium Channels can be regulated by multiple secondary messengers 
including cAMP and PKC. In addition, G proteins can directly modulate presynaptic VGCC. 
Activation of neurotransmitter-activated GPCRs negatively regulates Cav2 channel activity 
(Dolphin, 2003). Kathleen Dunlap and colleagues were the first to demonstrate that, 
neurotransmitters including norepinephrine (NE), γ-aminobutyric acid (GABA) and serotonin 
(5-HT) decreased calcium currents in cell bodies of embryonic chick dorsal root ganglion 
neurons (Dunlap and Fischbach, 1981) through a Pertussis toxin (PTX) sensitive G protein 
pathway (Holz et al., 1986) and the N-type calcium channel was the major target (Cox and 
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Dunlap, 1992). Later, neurotransmitter modulation of N-type and P/Q-type calcium channels 
was ubiquitously identified in cell bodies and presynaptic terminals. Despite intense 
investigation, the details of the various G protein modulation pathways and other secondary 
messenger regulation of calcium channels is not completely known (Dolphin, 1995; Dolphin, 
2003; Hille, 1994). 
 
1.4.1 Voltage Dependent G protein modulation 
The major form for G protein modulation of VGCC is a voltage-dependent inhibition 
resulting in the change on opening probability and gating kinetics of Cav2 family members 
P/Q-type (Cav2.1) and N-type (Cav2.2). Its characteristics and mechanisms have been 
thoroughly investigated by several groups (Catterall, 2000; Dolphin, 2003; Dolphin et al., 
1999; Tedford and Zamponi, 2006; Zamponi and Snutch, 1998) (Figure 3). Although there are 
many points of disagreement, some of the details of voltage-dependent G protein regulation 
are agreed upon: (1) Voltage-dependent G protein inhibition leads to a reduction of peak 
calcium current, slowing of activation and inactivation, and a positive shift in the 
current-voltage curve. The kinetic changes lead to a more pronounced inhibition at a less 
depolarized voltage. VGCC are considered to transfer from a “willing to open” state to a 
“reluctant to open” state under G protein modulation. (2) Treatment with pertussis toxin (PTX) 
usually abolishes transmitter-induced inhibition. Pertussis toxin catalyzes the 
ADP-ribosylation of specific G protein alpha subunits, such as Gi, Go and Gt, preventing 
them from interacting with GPCRs. (3) Calcium current inhibition appears to occur via a 
membrane-delimited pathway. It was found that calcium channels enclosed in cell-attached 
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patches were not affected by G protein modulation when agonist was added to the 
extracellular bath solution which could only activate GPCR outside the cell-attached patch. 
These data suggested that diffusible cytoplasmic messengers were not required in a 
mechanism that likely involved direct coupling of calcium channels with G proteins (Shapiro 
and Hille, 1993). (4) G-protein-dependent inhibition is strongly voltage dependent and can be 
temporarily relieved after strong depolarizations. Since the introduction of a double pulse 
facilitation reported by Stephen Ikeda (Ikeda, 1991), the paired pulse method is widely 
applied to compare the peak current with a strong prepulse larger than 100mV and the peak 
current without the prepulse. The voltage-dependent relief of inhibition is often referred as 
prepulse-dependent facilitation or paired-pulse facilitation (PPF). (5) It is Gβγ subunits that 
mediate the voltage dependent G protein modulation. Injecting Gβγ subunits in neurons could 
mimic the inhibition caused by neurotransmitters (Herlitze et al., 1996; Ikeda, 1996) and Gβγ 
subunits were also shown to bind with calcium channels (De Waard et al., 1997). 
 
1.4.2 Molecular determinants of Voltage Dependent G protein modulation 
The understanding of the molecular mechanisms of voltage dependent G protein 
modulation was greatly enhanced by gene cloning of VGCC genes, and in vitro heterologous 
expression in Xenopus oocytes (De Waard et al., 1997; Page et al., 1998; Qin et al., 1997; 
Zhang et al., 1996) and mammalian cell lines (Agler et al., 2005; Zamponi et al., 1997). The 
conclusion from these studies is that the N-terminus, the I-II linker connecting the first and 
second domains (DI and DII), as well as the C-terminus were proposed to be vital motifs in 
voltage-dependent G protein modulation. 
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A Gβγ binding motif “QQIER” was identified in the I-II linker of Cav2.2 (α1B, N-type) 
(Ikeda, 1996) and shown to associate with Cav2.1 (α1A, P/Q-type) (De Waard et al., 1997). 
Electrophysiological investigations with chimeric channels between α1A/α1B/α1C (Zhang et 
al., 1996) and between α1B/α1E (Dolphin et al., 1999; Page et al., 1998) and mutations in 
α1A (De Waard et al., 1997) suggested the I-II linker and the N-terminus were important for 
G protein modulation. One study reported that the C-terminal fragment of Cav2.3 (α1E,R-type) 
had a G protein modulatory site (Qin et al., 1997) while chimeras between α1A/α1B also 
suggested the involvement of the C-terminus (Zhang et al., 1996). However, most believe that 
the C-terminus plays an auxiliary role, if it has a role at all in voltage-dependent G protein 
modulation (Tedford and Zamponi, 2006). Some of the controversies may be attributed to the 
differences in cellular backgrounds for expression, choice of chimeras and varying amounts 
of voltage dependent and voltage independent G protein modulation. A most recent study 
(Agler et al., 2005) proposed that the N-terminus was fundamental to voltage dependent G 
protein modulation and formed an calcium channel inhibitory module with the I-II linker. 
 
1.4.3 Other G protein regulatory mechanisms 
Although the voltage-dependent pathway is widely spread, it is not the only way G 
proteins are known to regulate VGCC activity. It was suggested the inhibition of N-type 
calcium channels in rat superior cervical ganglion neurons was voltage independent and 
PTX-insensitive mediated through substance P activation while it was voltage dependent and 
PTX sensitive mediated by somatostatin (Shapiro and Hille, 1993). Intracellular application of 
PKC inhibitor could block the N-type inhibition produced by neuroepinephrine but not that 
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produced by GABA in embryonic chick sensory neurons (Diverse-Pierluissi and Dunlap, 
1993) and it was proposed later, through different G protein subunits that both voltage 
dependent and voltage independent pathways participated (Diverse-Pierluissi et al., 1995). 
Micro-injection of an RGS protein (Regulator of G-protein Signaling) into dorsal root 
gangalion neurons, was reported to alter the tyrosine kinase mediated voltage independent G 
protein inhibition (Schiff et al., 2000). Application of GABAB receptor agonist led to 
sequestering of calcium channels from the plasma membrane (Tombler et al., 2006). This 
suggests an alternative explanation of voltage independent G protein regulation that may not 
involve alteration in calcium channel activity.  
Recently, a specific, voltage-independent form of regulation was identified within a 
novel Cav2.2 isoform found only in nociceptive neurons in the dorsal root ganglia (DRG) 
neurons. This new splicing isoform contained a cell type specific 37a exon in the C-terminus 
of Cav2.2 and displayed the properties of both voltage-dependent and voltage-independent G 
protein modulation, while a unique tyrosine site might be responsible for its distinct voltage 
independent modulation property. Since ex37a is highly enriched in nociceptors, it might 
represent the natural adaptive response to pain (Bell et al., 2004; Ikeda and Dunlap, 2007; 







Figure 3: The model for voltage-dependent modulation of Cav2 calcium channel through G 

































1.5 An introduction to Lymnaea Stagnalis 
The Mollusca is the scecond largest phylum in terms of the number of species. The large 
size and easy manipulation of neurons are widely appreciated properties while the their 
membrane composition, ion channels and mechanisms of synaptic transmission do not differ 
in fundamental way from other invertebrates or even vertebrates (Chase, 2002). Nobel prize 
winners Hodgkin and Huxley used squid giant axon model to discover the ionic basis of 
membrane excitability (Hodgkin and Huxley, 1952) and Eric Kandel got the Nobel prize for 
his body of work that included mostly research on Aplysia californica (Kandel, 2004). 
Lymnaea Stagnalis, a widely distributed holarctic animal inhabited in freshwater 
ecosystems, belongs to the subclass of Pulmonata within the class of Gastropoda, in the 
phylum Mollusca, superphylum Lophotrochozoa. All pulmonate snails bear pallial lungs, 
while non-pulmonates gastropods in aquatic ecosystems bear gills. Pulmonate snails rise to 
the water’s surface to carry out gas exchange with the ambient air. The shell length of 
Lymnaeidae ranges from 2 to 6 cm. Although the dimensions of its central nervous system are 
small, the cells are highly pigmented and clearly visible. The nervous system of Lymnaea 
Stagnalis plays an important role in regulating respiration, blood circulation and water 
balance as well as controlling egg-laying behaviors (Chase, 2002).  
 
1.6 G protein modulation of LCav2 
Due to the complexity of mammalian VGCC genes and the difficulty to manipulate and 
work with identified neurons and synapses in mammals, invertebrates like Lymnaea stagnalis 
have become increasingly popular. Lymnaea stagnalis provides the following advantages for 
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neuroscience research. First of all, molluscs are part of the superclade lophotrochozoa which 
shares greater similarity with the human lineage in genome composition of nervous system 
related genes compared to the ecdysozoa which contains Drosophila and C. elegans (Moroz 
et al., 2006). Secondly, identified molluscan neurons are highly amenable for 
elecrophysiological manipulation. Isolated neurons cultured in vitro could form robust 
synapses, while maintaining most of their in vivo characteristics (McCamphill et al., 2008; 
Spafford et al., 2003b). Moreover, invertebrates like Lymnaea bear only three versus ten 
mammalian calcium channel genes. Lymnaea has single representatives of the L-type calcium 
channel family (LCav1), non-L type family (homolog to N-type,P/Q-type and R-type) (LCav2), 
and a T-type calcium channel: (LCav3) (Spafford et al., 2003b). All three of these calcium 
channel genes have been isolated from Lymnaea stagnalis. 
LCav2a, the major splice isoform in Lymnaea, is abundantly localized in presynaptic 
neurons and required for neurotransmitter release (Spafford et al., 2003b). Further, it was 
revealed that the biophysical characteristics of LCav2 current in vitro were similar to those of 
mammalian presynaptic N-type calcium channels (Spafford et al., 2003a). Blockade of LCav2 
currents by treatment with GTP-γS indicated that this channel could be modulated by G 
proteins like the N-type calcium channel (Spafford et al., 2003a). Serotonin was also shown to 
inhibit the presynaptic calcium currents through a G protein coupled pathway (McCamphill et 
al., 2008). However, the G protein modulation of LCav2 is qualitatively different, as the 
inhibition of GTP-γS could not be relieved by prepulses and was not reversible (Spafford et 
al., 2003a) (Figure 4). Preliminary investigations indicated that Lymnaea neuronal 
dihydropyridine-insensitive calcium currents in identified neurons and LCav2 channels 
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expressed in vitro did not possess the mammalian-type voltage-dependent G protein 
modulation capacity. 
The hypothesis of my proposed research is that LCav2 channels from Lymnaea do not 
possess the mammalian-type voltage-dependent G protein modulation capacity. Instead LCav2 
calcium channel displays a unique voltage independent G protein modulation rather than the 
voltage dependent G protein modulation, providing a unique opportunity to study the 
necessary structural motifs for different forms of inhibition by G proteins. 
The goals of my research project are to: 
a) Prepare an LCav2 channel construct for heterologous expression in mammalian cell 
lines  
b) Characterize the biophysical properties of LCav2 calcium channels 
c) Compare the voltage-dependent G protein modulation of invertebrate LCav2 calcium 
channels and mammalian rat rCav2.2 calcium channels 
d) Compare the effectiveness of the Lymnaea G protein β1 and mammalian G protein β1 
subunit in voltage-dependent G protein regulation 
e) Identify the structural determinants for voltage-dependent G protein modulation, by 
examining the functional consequences of swapping the cytoplasmic I-II linker and 
N-terminus from rCav2.2 into LCav2 channels 
Calcium channel regulation is complex and fine-tuned for regulating nerve synapses. 
Multiple pathways involving a large repository of protein cascades coexist in presynaptic 
neurons to adjust activity of Cav2 channels. These provide a large number of possibilities to 
respond to various signals and regulate neuronal excitability and synaptic plasticity. My MSc 
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Figure 4: The time course of LCav2 current corresponding to GTP-γS dialysis. Currents were 
elicited by stepping from -100 mV to +20 mV, and every second test pulse was preceded by a 
depolarizing prepulse (PP) to +150 mV for 50 ms (open symbols). For each experiment, all 
current amplitudes were normalized to the peak current value seen with the first test pulse. 
Once GTP-γS began to dialyzed into cytoplasmic solution after cell was ruptured, current 

































Chapter 2 Material and Methods 
2.1 Cloning WTLCav2-IRES-EGFP and derived chimeras 
To study the characteristics of LCav2 calcium channel, wild type LCav2 gene was cloned 
into pIRES2-EGFP vector using the following techniques: plasmid preparation, PCR, DNA 
purification, DNA ligation, DNA transformation, clone selection, while chimeras with mutant 
nucleotides were constructed based on a QuikChange Mutagenesis method.  
 
2.1.1 Bacterial Strains and Cloning, Expression Vector 
E.coli DH5α strain was the major bacterial strain used for cloning. While Stbl2 strain, 
derived from MAX Efficiency® Stbl2™ Competent Cells (SKU# 10268-019) from 
Invitrogen was used for cloning large fragments (above 5kb). Stbl2 cells were designed for 
cloning unstable inserts and are less likely to undergo recombination (recA minus). Different 
from 37 oC growing environment of DH5α, Stbl2 cells were incubated at a lower 30 oC.  
pIRES2-EGFP is the vector chosen for in vitro expression in mammalian cell lines. This 
plasmid contains a cytomegalovirus (CMV) promoter and a Kanamycin resistant gene. An 
internal ribosome entry site (IRES) was located between the multiple cloning sites and the 
coding region for enhanced green fluorescent protein (EGFP). To construct chimeras, a shuttle 
vector was derived based on pGEM-T which is a convenient cloning vector with an 
Ampicillin resistant gene.  
 
2.1.2 Plasmid Preparation  
Plasmid DNA was isolated by an alkaline lysis method separating the genomic DNA 
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from circular plasmid DNA. 3-5 ml overnight bacteria culture was spun down and 
resuspended in 100 μl of Solution I (50 mM glucose, 25 mM Tris (pH=8.0), 10 mM EDTA). 
200 μl of Solution II (1% SDS, 0.2N NaOH) was added to the tube and mixed gently. Then 
150 μl of ice cold Solution III (3.0 M KOAC, 11.45 % (v/v) Glacial acetic acid) was added. 
After centrifugation, the plasmid DNA remains in the supernatant while other bacterial 
components including chromosomal DNA rested in the precipitant. RNAse A (20 ug/ml) was 
added to prevent RNA contamination. 50:50 phenol/chloroform mixture was added and spun 
for 10 min to separate upper aqueous phase containing purified plasmid from contaminating 
proteins in the lower phase. Two volumes of 100% ethanol and sodium acetate to 0.3 M (1/10 
volume of 3M sodium acetate) was added and spun for 10 minutes to pellet the plasmid DNA. 
DNA pellets were washed with 70% ethanol, air-dried, and resuspended in sterile water. 
Absorbance at OD260 was read on a UV spectrophotometer (Nanodrop ND1000) to quantify 
the purified plasmid DNA (1 OD unit = 50 ug/ml of dsDNA). 
To isolate plasmids for transfection, GenElute HP Endotoxin-Free plasmid Maxiprep Kit 
purchased from Sigma-Aldrich (NA0400S, NA0400) was used to eliminate endotoxins which 
could hinder high transfection efficiencies.  
 
2.1.3 DNA purification 
DNA was re-purified between molecular biology protocols, such as after agarose gel 
electrophoresis, restriction enzyme digestion reactions, and DNA ligation reactions. Most 
DNA gel band purifications were carried out using a QIAquick Gel Extraction Kit (Cat No. 
28704) purchased from Qiagen, or GFX PCR DNA and Gel Band Purification Kit (Lot 
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352860) purchased from GE Healthcare. Purifications of DNA gel band larger than 10kb 
required QIAEX II Gel Extraction Kit (Cat No. 20021) purchased from Qiagen or e.Z.N.A. 
Gel Extraction Kit (D2500-02) purchased from Omega. 
 
2.1.4 Polymerase Chain Reaction 
PCR (Polymerase Chain Reaction) was used to amplify DNA sequence for cloning and 
to carry out site-directed mutagenesis experiments. All primers are ordered from 
Sigma-Aldrich and dissolved in autoclaved MiniQ water as 100 uM and 20 uM working stock 
solutions. Information of all primers is listed in Appendix1. For a standard PCR using a 
thermocycler, DNA was first denatured at 94oC for 2min. Then DNA was denatured at 94oC 
for 30s, then annealed at 60oC for 45s, and elongated at 72oC for 1min, and repeated for 25-40 
cycles. A final DNA elongation step was held at 72oC for 10min. PCR reagents such as Taq 
Polymerase were purchased from Fermentas. An Eppendorf Mastercycler EP silver block 
thermocycler was used for synthesizing DNA in the PCR reaction. 
 
2.1.5 Competent cell preparation and heatshock transformation 
To introduce ligation system or plasmid DNA into bacterial, chemical competent DH5α 
and Stbl2 cells were prepared using a modified Hanahan protocol. Overnight culture was fed 
into 250 ml flask containing 100 ml of LB and grown until culture density reaches an OD600 
spectrophotometric reading of ~0.5. Then bacterial pellet was gathered and resuspended 
gently in 16 ml of RF1 Solution (100mM Rubidium Chloride, 50mM Manganese Chloride, 
30mM Potassium Acetate,10mM Calcium Chloride, 15%w/v Glycerol, pH=5.8, filter 
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sterilized) and incubated on wet ice for 1 hour. Bacteria was repelleted and resuspended 
gently in 4 ml of RF2 Solution (10mM MOPS, 10mM Rubidium Chloride, 75mM Calcium 
Chloride, 15% (w/v) Glycerol) and incubated on wet ice for 15 minutes. Then 100 ul of 
chemically-competent cell suspension was dispensed into each pre-cooled microcentrifuge 
tubes and then quickly frozen in liquid nitrogen. Competent cells were able to take in DNA 
molecules using heatshock transformation. 
 
2.1.6 Quantification of Nucleic Acids, Agarose Gel Electrophoresis, DNA Ligation, DNA 
Digestion and DNA Dephosphorylation 
Nucleic acids were quantified using Thermo Scientific NanoDropTM 1000 
Spectrophotometer, which permits analyses with a 2 μl sample. Agarose gel electrophoresis 
for DNA was carried out at 1% to 2% agarose concentration in TAE buffer. New England 
Biolabs was the source of most enzymes used for molecular biology protocols, including: T4 
ligase, restriction endonucleases and Antarctic Phosphatase for removing 5’phosphate groups 
from DNA. 1kb plus DNA ladder was purchased from Fermentas. 
 
2.1.7 QuikChange Mutagenesis 
QuikChange Mutagenesis was used to introduce DNA mutations of calcium channels to 
generate chimeras. In this procedure, the mutations were synthesized into DNA strands in the 
PCR with overlapping primers which incorporated the site directed mutations into a circular, 
nicked plasmid. The length and composition of the mutagenic primers were designed with the 
aid of Stratagene’s web-based QuikChange® Primer Design Program, which is available 
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online at http://www.stratagene.com/qcprimerdesign and reaction was optimized using an 
experimentally-derived concentration of template (5ng, 10ng, 25ng, 50ng).  
For QuikChange Mutagenesis PCR, a mixture of Vent and Taq Polymerase (1:20) was 
used and the PCR thermocycling protocol was modified as follows: DNA was denatured at 
95oC for 2 min. For 12 cycles, DNA was denatured at 95oC for 30s, then annealed at 58oC for 
1min, after which the DNA would be elongated at 72oC for 10min. Non-PCR generated 
plasmid DNA template from bacteria which is always methylated was selectively digested by 
DpnI. DpnI-resistant, PCR-mutagenized DNA was transformed into competent bacteria cells 
where the circularized plasmid was repaired of nicks and multiplied in dividing bacteria.  
 
2.2 Expressions of calcium channels in mammalian cell lines 
To characterize the LCav2 channel, wild type genes as well as chimeras were transfected 
into mammalian cell lines for expression. 
 
2.2.1 Mammalian Cell lines 
Rat and snail calcium channels as well as G-protein subunits harbored in mammalian 
expression vectors were heterologously-expressed, by transfecting into human embryonic 
kidney cell line (HEK293T) obtained from American Type Culture Collection (ATCC). 
HEK293T cells do not contain detectable levels of endogenous calcium channel subunits, 
serving as the appropriate surrogate for examining the in vitro expressed channels. The 
HEK293T is a highly transfectable derivative of the 293 cell line into which a stably plasmid 
containing the SV40 large T antigen is integrated. This maintains a high copy number of 
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plasmids expressed episomally, such as vectors used in my study (pCDNA, PMT2 or pIRES2) 
which contain the SV40 mammalian origin of replication.  
 
2.2.2 Passage of HEK293T Cell Line 
HEK293T (tsA-201) cells were grown in standard complete medium (DMEM 
supplemented with 1mM Sodium Pyruvate, 10%FBS, 50units penicillin and 50μg /ml 
streptomycin) as a monolayer in disposable culture flask to 85% confluency at 37oC in a CO2 
(5%) incubator. Every 3-4 days, 293T cells were passaged to a new flask by 1:6 dilution. To 
propagate the 293T cell line, cells were loosened from flask bottom with 0.5ml of trypsin, 
incubated at 37oC for 3-5 minutes before diluting in at least 1:10 complete media to inactivate 
the trypsin. Resuspended culture not used for maintaining the new passage were replated in 6 
ml aliquots to 60 mm (diameter) sterile petri dishes containing 3 to 6 pre-sterilized 
poly-lysine coated glass coverslips (Circles No. 1 - 0.13 to 0.17mm thick; Size: 12mm, Fisher 
Scientific) for transfection and electrophysiology recording. 
DMEM (Dulbecco’s Modified Eagle’s Medium, Cat No. 5796), sodium pyruvate 
solution (100mM, Cat. No. 8636), FBS (Fetal Bovine Serum Cat. No. F1051), Pen/Strep 
(5000 units penicillin and 5mg streptomycin/ml, Cat. No. P4458) and trypsin-EDTA (0.25%, 
Cat. No. T4049), were all purchased from Sigma-Aldrich Chemical Company. Fetal Bovine 
Serum was heat inactivated at 56oC for 15 minutes before use.   
 
2.2.3 Calcium Phosphate Cell Transfection  
Genes harbored in plasmids were introduced into HEK293T cells for protein expression 
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by standard calcium phosphate transfection method (Spafford et al., 2003a). In this technique, 
cells were split into 60mm dishes at approximately 50% confluency and settled for at least 3-4 
hours before transfection. Around 10 μg of Plasmid DNA for transfection was added to sterile 
water to a final volume of 225 μl. 25 μl of 2.5M CaCl2 was added to the DNA mixture then 
250 μl of 2xHES buffer (280mM NaCl, 50mM Hepes, 1.5mM Na2HPO4: 7H2O) was added 
drop by drop. Calcium phosphate crystals containing DNA plasmids would form after 20 
minute incubation at room temperature before being applied on adherent HEK293T cells (in 
4.5ml cell culture media). Calcium phosphate crystals were mixed in culture dishes plated 
with cells by gentle swirling and left to incubate overnight at 37oC in a CO2 incubator. The 
next morning, cells were washed in PBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 
2mM KH2PO4, pH=7.2-7.4) three times and replaced with 6 ml of fresh media. Cells were 
allowed to recover from washing at 37oC for 2 hours then left in CO2 incubator at a 30oC for at 
least 48 hours before patching. The lower 30oC temperature for incubation of cells promotes 
protein expression at the expense of cell division. In 100mm dishes, 20 μg of DNA, 50 μl of 
2.5M CaCl2, 500 μl of 2xHES buffer were used and the final transfection volume was 1ml, 
while cells were plated in 9ml complete media. 
 
2.2.4 Lipofectamine transfection   
Lipofectamine™ 2000 Transfection Reagent (11668-019) purchased from Invitrogen, is a 
proprietary cationic lipid formulation that offers high transfection efficiency and protein 
expression levels for HEK293T cells (Raingo et al., 2007). Based on the manufacturer’s 
protocol, HEK293T cells were allowed to settle on coverslips in 60mm dish to 70% 
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confluency then the complete media was changed to 5 ml of non-antibiotic media before 
transfection. 20 μl of lipofectamine reagent in 500 μl of pure DMEM was mixed with 10 μg 
of DNA which was also dissolved in 500 μl of pure DMEM, and allowed to be incubated at 
room temperature for 10 minutes before adding the transfectant mixture to cell culture dishes.  
 
 
2.3 Electrophysiological Recordings 
Whole cell recording is an electrophysiological recording method to study the activity of 
ion channels in cell membranes. 
 
2.3.1 Solutions and Materials 
Calcium channel activities were measured by the whole-cell patch clamp technique. 
Transfected HEK293T cells were bathed and recorded in external solution containing barium 
as the charge carrier (20mM BaCl2, 1mM MgCl2, 10mM HEPES, 40mM TEA-Cl, 65mM 
CsCl, 10mM Glucose, adjust pH to 7.2 with TEA-OH, filter through 0.22μm filter). Barium is 
a preferred charge carrier because it passes through calcium channels more easily than 
calcium (currents in barium are twice as large as calcium) and barium does not 
activate/inactivate calcium-dependent intracellular signaling cascades. Ground electrodes 
were connected to the bath by a salt bridge, made from 5cm borosilicate glass (O.D.=1.5mm, 
I.D.= 0.086mm, item# = BF150-86-15) containing 2% agarose gel in 3M CsCl. Patch pipettes 
(2-5MOhms) are pulled from 7.5cm borosilicate glass (with filament, item# = BF 150-86-15) 
using a Model P-97 Flaming/Brown Micropipette Puller (Sutter Instrument Company) and 
polished using a MF-830 Micro Forge ( Narishige, Japan). Patch pipettes were filled with 
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internal solution (108mM Cs-methanesulforate, 4mM MgCl2, 9mM EGTA, 9mM HEPES, 
adjust pH to 7.2 with CsOH, filter through 0.22μm filter), mimicking the components of 
cytoplasmic solution. 
 
2.3.2 Whole cell recording 
Whole cell patch clamp technique enables the analysis of the activity of ion channels in 
the cell membrane (Figure 5). Cells positively transfected with calcium channel subunits were 
identified by green fluorescence, emitted by EGFP either on the pIRES2-EGFP plasmid 
containing LCav2 calcium channels, or on the pEGFP plasmid cotransfected. Green 
fluorescence was activated by mercury lamp on a Zeiss Axiovert 40 or 100 epifluorescence 
microscope with D455/70 nm band-pass filter. To carry out a recording, a patch of cell 
membrane was sealed and ruptured by the patch pipette with patch resistances between 
2-5MΩ. Electrophysiological recordings were carried out in voltage-clamp mode at room 
temperature, where the membrane potential was clamped to a series of specified, commanded 
voltages by injecting current. In brief, the patch pipette was slowly lowered into the bath 
solution using a motorized manipulator until the pipette contacts with the cell membrane, 
yielding a slight increase in pipette resistance (~1 MΩ increase). Suction was then applied to 
patch pipette to form a gigaseal, with a pipette resistance above 1GΩ. When the gigaseal 
became stable, the cell was held at a holding potential of -100mV, and strong suction was 
applied to rupture the cell membrane under the patch pipette without breaking the seal at the 
edge of the glass-membrane interface.  
Whole cell recordings were made with an Axopatch 200B amplifier (Axon Instruments, 
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Union City, CA), while monitored by the epifluorescence microscope (Axiovert 40 CFL, 
Zeiss). The voltage command generation and data acquisition were carried out using a PC 
computer equipped with a Digidata 1440A interface in conjunction with pClamp10 software 
(Molecular Devices). Recorded currents were filtered at 10 kHz using a low-pass Bessel filter 
and digitized at a sampling frequency of 2 kHz.  
 
2.3.3 Data analysis 
All data were stored as ABF extension form and off-line leak subtraction was carried out 
using ClampFit, an analysis program for electrophysiological data, when necessary. Figures 
were created in Origin 10, a professional data analysis and graphing software. 
To observe the expression of calcium channels, a voltage step protocol for 450ms at 
+20mV from a -100mV holding potential was first applied to activate an inward barium 
current. For each single trial, the values of the current at every time points were collected, and 
normalized to the peak. The normalized data were averaged (Mean) then the standard errors 
(SE) were calculated. Data were illustrated as Mean±SE to be plotted against the time points, 
where activation and inactivation were compared. The inactivation decay of the currents were 
exponential curve fit from just after peak current to current of maximal decay in the 450 ms 
step pulse. The exponential equation is I=A1*exp(-t/τ)+A2 where I is the normalized current 
amplitude, t is the time length after the peak and τ is the time constant for inactivation decay. 
To characterize voltage sensitivities of the calcium channel, the current-voltage 
relationship was obtained by holding cells at -100mV before stepping to test potentials 
ranging from -50 to +60mV for 150ms. In each single trial, the values of peak current at each 
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holding potential were assembled together and normalized to the maximum. Normalized sets 
of data for each test were averaged (Mean), then the standard errors (SE) were calculated. The 
normalized peak currents were plotted to commanded voltages, generating the I-V 
relationship figure. 
Steady state inactivation reflecting the voltage dependent of inactivation was also 
explored. Peak currents were examined at a test depolarization step to +20mV from -100mV 
holding potential, after 4s prepulse holding potentials ranging from -90 to +30mV. Values of 
peak currents after different prepulse holding voltage were collected and normalized to the 
maximum peak curret. Then these normalized data were averaged and curve fit with a 
Boltzman equation I=A1+A2/[1+exp(V-Vh/S)] (Spafford et al., 2006) where I is the 
normalized peak current amplitude, V is the prepulse holding potential, Vh is the 
half-inactivation potential and S is a slope factor. 
To study the voltage dependent G protein facilitation, paired pulse protocol was used to 
observe the prepulse facilitation. Facilitation was recorded by providing a +150mV strong 
depolarization lasting for 50ms, 25ms before the 40ms +20mV testing potential, while cells 
were held at -100mV. Facilitation was calculated by dividing the value of the peak current 
with a prepulse to the value of the peak current without a prepulse. Data among each group 







Figure 5: Schematic illustration of whole cell mode patch clamp. A coverslip plated with 
transfected HEK cells was placed in external solution in a 30mm dish. Positively transfected 
cells (green) were recorded with a glass pipette filled with internal solution. Currents were 
measured as the difference between the patch electrode and a ground electrode in the bath. 
Voltage clamp protocols were delivered by computer commands through Axopatch 200B 






























Chapter 3: Results 
3.1 Cloning and Expression of wild-type LCav2 
3.1.1 Construction of WTLCav2- EGFP plasmid 
An LCav2 calcium channel isolated from Lymnaea stagnalis and expressed in vitro 
previously was studied. The initial expression construct was a cDNA derived sequence 
contained in a pMT2 mammalian expression vector and the LCav2 N terminus was replaced 
by an N terminal sequence from rCav2.1 calcium channel, the P/Q type calcium channel 
isolated from rat, to boost in vitro channel expression on the membrane (Spafford et al., 
2003a). Since critical cellular interactions were expected to involve the N-terminus, including 
G protein modulation, the first step in my project was to reclone LCav2 with the native 
N-terminus, and second, to transfer LCav2 into pIRES2-EGFP vector which was more 
amenable for selection of positive transfectants in mammalian cells than the pMT2 vector. 
pIRES2-EGFP is a bicistronic vector containing an internal ribosome entry site (IRES) 
between the multiple cloning sites containing the gene of interest (ie. LCav2 calcium channel) 
and the coding region for enhanced green fluorescent protein (EGFP). This enables the 
co-expression of calcium channel with the EGFP, whose fluorescent level could be visualized 
using an epifluorescence microscope.  
The final LCav2 in pIRES2-EGFP plasmid (WTLCav2-IR-EGFP) was constructed as 
followed (Figure 6): Step 1, 5’ 2.2 kb from 5’RatCav2.1- LCav2-pMT2 clone, the initial 
plasmid with a N-terminal sequence from rCav2.1 channel, was cut and ligated into a 
pIRES2-EGFP vector replacing a BarkCT (Carboxyl-Terminus of the Beta Adrenergic 
Receptor Kinase) gene, using an SalI restriction sites; 2, The N terminus from wild type 
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LCav2 sequence replaced the rCav2.1 by insertion of a PCR product (XhoI-MluI) resulting in 
N-terminal 2.2 kb wild-type LCav2 channel in pIRES2-EGFP (WT2.2-pIRES2-EGFP); 3, 
Most of the C-terminal 4.4kb sequence from 5’RatCav2.1- LCav2-pMT2 clone was appended 
to N-terminal 2.2 kb fragment in pIRES2-EGFP using SacI restriction sites (SacI- 
LCav2-pIRES2-EGFP); 4, the C terminal 350bp sequence of LCav2 was generated in the PCR 
from 5’RatCav2.1- LCav2-pMT2 to create a compatible XmaI restriction site at the 3’ end 
(SpeI-XmaI) (forward: Primer 1#, LCav2SpeIf; Backward: Primer 2#, LCav2CT-XmaI) into 
the pIRES2-EGFP plasmid.   
After this series of cloning steps, the final plasmid was confirmed by restriction enzyme 
digestion (Figure 7). All PCR amplified sequences were confirmed by DNA sequencing. The 
length of full-length WTLCav2-IR-EGFP sequence is 11704 bp with insert of 6423 bp coding 
for LCav2 gene encoding 2141 amino acids (GenBank: AAO83841). 
 
3.1.2 Transfection and Expression of LCav2 calcium channels  
Due to the existence of many neuronal signaling pathways, the low endogenous calcium 
channel expression, and the easy accessibility for patch clamp, the HEK293T cell line was 
chosen for in vitro calcium channel expression (Berjukow et al., 1996; Thomas and Smart, 
2005). HEK293T cells were transfected by calcium phosphate precipitation in 100 mm dishes 
with DNA plasmids encoding calcium channel subunits: either 8μg LCav2 (pIRES2-EGFP) or 
8μg rCav2.2 (a rat α1 subunit homolog) and <1 μg pEGFP were used, supplemented with 6μg 
rβ1b (pMT2) and 6μg rα2-δ (pMT2). The transfection of rCav2.2 was supplemented with 
pEGFP because this gene was located in a pMT2 vector without a EGFP gene. In 60mm 
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dishes, the amount of transfected subunits were reduced to 3-4μg LCav2 (pIRES2-EGFP) or 
rCav2.2 and EGFP, 3-4μg rβ1b (pMT2) and 3-4μg rα2-δ (pMT2). The expression level of 
EGFP correlated with the transfection efficiency and served as a marker for calcium channel 
subunit expression. According to the amount of cells with green fluorescence, the transfection 
efficiency was above 50%. 4-6 days after transfection, the cells were suitable for recording 
with enough expressed channels and good cell conditions. Biochemically, the expression of 
LCav2 was detected by immunostaining using chicken anti-LCav2 antibody which recognizes 
an extracellular epitope of LCav2 (Figure 8). Electrophysiologically, the functional expression 
of LCav2 could be assessed using a voltage step protocol during whole cell patch clamp 
recording (Figure 9). In brief, a quickly activated/inactivated inward barium current was 
generated when the cell was held at a depolarizing +20mV testing potential lasting 450ms 
while the resting potential was held at -100 mV. 
 
3.1.3 Biophysical comparisons of LCav2 and rCav2.2 
Both LCav2 and rCav2.2 are structural and functional homologs, which are localized in 
presynaptic neurons and play an essential role in synaptic transmission in snails (Spafford et 
al., 2003b) and mammals (Mochida et al., 1996). Despite their similarities in overall function, 
there are differences in structure. Alignment reveals only 43.6 % identity between the 
full-length isoforms of LCav2 (2141 amino acids) and rCav2.2 (2333 amino acids). 58% of 
amino acid residues are identical or highly similar to each other, and 33.4% are completely 
different in an alignment (ClustalW). To understand whether there is conservation in their 
biophysical properties, current-voltage relationship, inactivation decay and steady state 
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inactivation curve of LCav2 were characterized. For typical membrane ion channels, there are 
three different states: closed, open, and inactivated. Hold the membrane potential at resting 
potentials, most channels would be closed. When the membrane potential reaches a threshold, 
the channels would begin to open and mediate the passage of ions. Once activated to open, 
channels have a tendency to inactivate where the channels no longer respond to membrane 
potential changes and will not re-open, unless there is a strong membrane hyperpolarization 
which promotes the channels changing states from an inactivated state to a closed state. 
Current-voltage relationship, inactivation decay and steady state inactivation is to study the 
voltage dependent activation, time dependent inactivation and voltage dependent inactivation 
of channels respectively. 
Current-voltage relations were generated using normalized peak barium current values, 
with a 150ms testing potential, stepping from -50mV to 60mV at 10mV intervals. A sample 
ensemble of traces is shown in Figure 10. Data from multiple cells were averaged and plotted 
as current-voltage relationships as shown in Figure 11. LCav2 and rCav2.2 have 
indistinguishable voltage-sensitivities: both start activating around -20mV and reach the peak 
at approximately +20mV.    
Peak current data can be used to estimate the kinetics of inactivation decay, quantified 
from just after the peak current value to the 450 ms time point where there is substantial 
inactivation of current (at least 70%) (n=7 or 8 different cells) (Figure 12). Exponential fit 
was applied to analyze the inactivation decay, with R values of 0.98165 and 0,99675 for 
LCav2 and rCav2.2 respectively indicating successful fittings. Compared to rCav2.2, 
inactivation rate of LCav2 was faster. The time constant (τinact) for LCav2 was 43.2±
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1.22ms (mean ± SE) while that for rCav2.2 was 130.6±0.85ms. Activation rates also 
appeared to be a faster for LCav2. 
The voltage-sensitivities for inactivation were explored by steady-state inactivation. In 
this protocol, cells are held at holding potentials ranging from -90mV to 50mV for 4s until a 
steady-state fraction of calcium channels undergoing inactivation is achieved. This is 
followed by a voltage step to +20mV for 150ms in duration to measure the residual channels 
that are available for opening at a steady state. Normalized current values of steady state 
inactivation were plotted to the 4s prepulse holding potentials A Boltzmann fit of the 
steady-state inactivation curve (Figure 13) indicated that LCav2 was half inactivated around 














Figure 6: Illustration of the cloning strategy to construct LCav2 gene into pIRES2-EGFP 
vector from 5’ RatCav2.1-LCav2-pMT2 in pMT2 vector. Step 1, 5’ 2.2 kb from 
5’RatCav2.1-LCav2-pMT2 clone was cut and ligated into a pIRES2-EGFP vector using an 
SalI restriction sites; Step 2, The N terminus from wild type LCav2 sequence replaced the 
rCav2.1 by insertion of a PCR product (XhoI-MluI) resulting in WT2.2-pIRES2-EGFP; Step 3, 
Most of the C-terminal 4.4kb sequence from 5’RatCav2.1- LCav2-pMT2 clone was appended 
to N-terminal 2.2 kb fragment in pIRES2-EGFP using SacI restriction sites (SacI- 
LCav2-pIRES2-EGFP); Step 4, the C terminal 350bp sequence of LCav2 was generated in the 
PCR from 5’RatCav2.1- LCav2-pMT2 and cloned into the pIRES2-EGFP plasmid using SpeI 
and XmaI restriction sites. Restriction sites chosen for cloning are colored in blue. Inserted 
fragments for each ligation reaction are marked by blue line. This illustration was created 




Figure 7: Restriction Digestion Map of WTLCav2-IR-EGFP, the final plasmid containing wild 
type LCav2 gene in pIRES2-EGFP vector. Lane M is 1 kb plus DNA ladder, with 3 brightest 
bands of 5kb, 1.5kb and 500bp respectively. Lane 1 is blank; lane 2 and lane 3 are both 1μg 
plasmid DNA of construct digested by BglII, displaying multiple bands of 5480bp, 2842bp, 
2335bp, 660bp, 366bp and 21bp (unseen) as expected; lane 4 is 1μg plasmid DNA digested 
by HindIII, displaying multiple bands of 5289bp, 3359bp and 2956bp as expected. Lane 5 is 




























Figure 8: Immunostaining of LCav2 transfected HEK-293T cells. After fixation, cells were 
incubated with 1:1000 chicken anti-LCav2 antibody which recognizes a cytoplasmic epitope 
coding for KAEDNENDSEQNDND. Anti-LCav2 antibody was visualized with 
fluorescently-coupled AlexaFluor633 dye conjugated Goat anti-chicken secondary antibodies. 
Panel A indicates green fluorescence of the EGFP expressed from WTLCav2-IR-EGFP 
plasmid; panel B indicates AlexaFluor 633 fluorescence of secondary antibody; panel C is 
Differential Interference Contrast (DIC) image under a Zeiss 510 Meta confocal microscope 




















Figure 9: Sample trace of LCav2 barium current. The top panel shows the commanded voltage, 
consisting of a +20mV step depolarization lasting for 450ms from an initial holding potential 
at -100mV. The panel at the bottom shows the corresponding current elicited by the voltage 



















Figure 10: Sample ensemble current traces of LCav2 (bottom trace) elicited by voltage steps 
(top trace) when barium was the charge carrier. Currents were generated by 150 ms testing 


















Figure 11: Current-voltage relationship comparisons of LCav2 and rCav2.2 calcium channel 
homologs. Under identical conditions (20mM barium contained in extracellular solution), 
both LCav2 and rCav2.2 started to activate at -20mV and reached the maximal current values 
at approximate +20mV. Data from seven LCav2 transfected and six rCav2.2 transfected cells 


























Figure 12: Comparisons of the inactivation decay. Hold at -100mV, membrane potential 
stepped to +20mV for 450mS. Barium currents through Cav2 calcium channel homologs, 
LCav2 and rCav2.2 were elicited. Normalized mean values of current data at each time point 
from seven LCav2 and eight rCav2.2 cells were shown. Tau values for inactivation decay were 
calculated by exponential fitting and were 43.2±1.22ms and 130.6±0.85ms for LCav2 and 
rCav2.2, respectively. Data were illustrated as mean value ± standard error. Numbers in the 



























Figure 13: Steady state inactivation curves for LCav2 and rCav2.2 barium currents. A four 
second depolarizing step was applied to inactivate a fraction of channel activity at different 
voltages (-90 mV to +70 mV) evaluated by a test pulse at peak current (+20mV for 150 ms). 
Voltage command protocol (top panel) and steady state inactivation curves are shown. The 
half-inactivated voltage potential was -39.8±0.82 mV and -49.6±1.45 mV for LCav2 and 

















3.2 LCav2 Calcium Channel Lacks Voltage Dependent G Protein Modulation 
Preliminary investigation indicated similarities between LCav2 and rCav2.2 in 
biophysical characteristics. These channels also play homologous roles in the nervous system 
as mediators of synaptic transmission. Modulation of synaptic calcium channels by 
neurotransmitter-gated, G protein coupled receptors is a primary means to alter synaptic 
efficacy in mammalian synapses, by inhibition of calcium channels. The primary form of G 
protein regulation in mammals is the voltage-dependent inhibition, which can be relieved by 
strong depolarizing prepulses. Preliminary investigation of G protein regulation in 
invertebrates appears to be qualitatively different from the mammalian voltage-dependent G 
protein modulation: Treatment of LCav2 channels with a non-hydrolysable GTP analog, 
GTP-γS leads to constitutive activation of G proteins, and a voltage-independent G protein 
modulation, where peak currents run down over time without relief of the inhibition by 
depolarizing prepulses (Spafford et al., 2003b). Depression of presynaptic neurotransmission 
was by inhibiting calcium currents through a cAMP-mediated G-protein-coupled pathway 
(McCamphill et al., 2008).  
To analyze whether the G protein modulation of LCav2 involved the direct, 
voltage-dependent inhibition by G protein beta and gamma subunits, 8μg LCav2 channels 
were coexpressed with 2μg rat Gβ1 and Gγ2 subunits per 100 mm culture dish for transfection. 
Since Current-Voltage relationship of both channels peaked at +20mV, the voltage 
dependence of G protein modulation was measured by a paired-pulse protocol, by examining 
the effect of a strong depolarization (+150mV for 50ms) 25 ms before a test pulse (a +20mV 
step depolarization to +20 mV). A paired-pulse facilitation (PPF) ratio was measured by 
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comparing the size of the peak current aroused by the test pulse in the presence and absence 
of the depolarizing prepulse, reflecting the degree of voltage-dependent relief from G protein 
modulation. If the PPF ratio is significantly above one, which means the peak current with a 
prepulse is larger than that without a prepulse, a voltage dependent G protein modulation is 
present. LCav2 currents were unaffected by a strong depolarizing prepulse (Figure 14), 
compared to rCav2.2, where the paired-pulse facilitation ratio was significantly larger than 
one. Data from multiple cells were analyzed (Table 2). In the presence of co-expressed G 
protein beta gamma subunits, the PPF ratio was 1.95±0.11, n=8 for rCav2.2. Background 
endogenous expression of G protein beta gamma subunits in HEK293T cells provides a 
reduced (1.37±0.07, n=9) but still statistically significant pre-pulse facilitation with rCav2.2. 
In comparison, LCav2 channels without or with coexpression of G protein beta gamma 
subunits, bore a PPF ratio around one (1±0.03, n=8, and 0.95±0.03, n=7, respectively). 
Statistical analysis using Multiple Turkey Test (p<0.05) revealed relative degrees of PPF were 
rCav2.2/Gβγ > rCav2.2 > LCav2/Gβγ ~ LCav2. The LCav2 ratio was near one reflecting a lack 
of voltage dependent G protein modulation for LCav2 channels (Figure 15).   
The absence of voltage-dependent G protein modulation might be caused by the 
incompatibility of the rat G protein beta subunit with the snail calcium channel. Lymnaea G 
protein beta1 bears protein identity of 83.9%, 83.6%, 79.8% and 81.8% with rat G protein 
beta1 through beta4 respectively. The only G protein beta subunit that contributes very little G 
protein modulation, G protein beta 5 (Arnot et al., 2000; Doering et al., 2004) is more distant 
to Lymnaea G protein beta1 with a gene identity of 50.7%. Even with coexpression of 
Lymnaea G beta1 instead of rat G beta1, voltage-dependent G protein modulation of LCav2 
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channels was still evidently lacking, since the paired-pulse facilitation ratios were near unity 
(1.02±0.117, n=2) (figure 16). Interestingly, coexpression of rCav2.2 with Lymnaea G 
protein beta subunits, did not significantly alter the PPF ratio compared to endogenous G 
protein modulation (1.33±0.1, n=3) (figure 16). The apparent absence of contribution of 
Lymnaea G protein beta subunits to pre-pulse facilitation of Cav2.2 channels indicated that the 
G protein beta subunit as well as the Cav2 calcium channel in Lymnaea lacked the structural 

















Figure 14: Sample trace of pre-pulse facilitation of LCav2 and rCav2.2 with the exogenous 
expression of rat Gβ1γ2 subunits. With a prepulse (150 mV for 50ms in duration, 25ms 
preceding the test pulse), the peak current of LCav2 did not change while the peak current of 
rCav2.2 was almost twice as large as the original value. Picture inset illustrates the pre-pulse 




























Table 2: Paired-Pulse Facilitation (PPF) ratios describing the voltage dependent G protein 
modulation of Cav2 channels, LCav2 or rCav2.2 in the presence and absence of co-expressed, 
exogenous rat Gβγ subunits. All the data points used for Figure 15 are provided in the table 
below. 
 
LCav2 0.9535 1.1853 1.0055 0.9829 1.0413 0.9543 0.8694 0.9902  
LCav2/Gβγ 1.0422 0.8039 0.8704 0.9720 1.0326 0.9269 1.0052   
rCav2.2 1.6604 1.4959 1.0798 1.2127 1.2259 1.1473 1.5574 1.4863 1.4528 
rCav2.2/Gβγ 2.0709 2.1150 1.3426 2.2203 1.9444 1.8465 2.3015 1.7275  














Figure 15: Histogram summarizing the paired-pulse facilitation (PPF) of invertebrate LCav2 
and mammalian rCav2.2 calcium channels. Columns were illustrated as mean±SE. The ratios 
of the amounts of transfected subunits were: Cavα1: Cavβ: Cavα2δ: rGβ: rGγ = 4: 3: 3: 1: 1. 
The PPF ratios for LCav2 and rCav2.2 alone were 1±0.03 (n=8) and 1.37±0.07 (n=9). With 
the coexpression of Rat Gβ1γ2, the PPF ratio were 0.95±0.03 (n=7) and 1.95±0.11 (n=8) 
respectively. The PPF ratios were larger than one for rCav2.2 indicated that rCav2.2 channels 
had voltage-dependent relief of G protein inhibition from a depolarizing pre-pulse while PPF 
ratios were near unity for LCav2 indicating an absence of voltage-dependent G protein 





















Figure 16: Histogram illustrating the paired-pulse facilitation of mammalian rCav2.2 and 
invertebrate LCav2 channels coexpressed with invertebrate G protein beta subunit LGβ1. 
Columns are shown as mean values with SE error bars. The paired pulse facilitation ratios for 
LCav2 and rCav2.2 were 1.02±0.117 (n=2) and 1.33±0.1 (n=3) respectively. The PPF values 
for both LCav2 and rCav2.2 with Lymnaea G protein beta1 subunit were not different from 
data collected from calcium channels without exogenous G protein subunits co-expression. 
These data suggested that the Lymnaea G protein beta1 subunit might not be structurally 






















3.3 Calcium channel structures responsible for voltage-dependent G protein modulation 
Voltage dependent G protein modulation of Cav2 calcium channels is reported to be 
mediated through interaction between Gβγ subunits and the α1 subunit of either vertebrate 
Cav2.1 and Cav2.2 α1 calcium channels (Tedford and Zamponi, 2006). The major site of 
interaction is two consensus binding sites in the cytoplasmic linker between Domains I and II 
(I-II linker region) of Cav2.1 and Cav2.2 channels. A recent report suggested that the 
N-terminus of Cav2 channels might also interact with the I-II linker and were essential for the 
G protein modulatory effect (Agler et al., 2005). Sequence alignment between rCav2.2 and 
LCav2 indicates discrepancies in the N-terminal and I-II cytoplasmic linker regions (Figure 
17). To explore which structure module is vital for voltage dependent G protein modulation, 
we tried to swap the I-II linker and the N-terminus from rCav2.2 into LCav2, attempting to 
confer voltage dependent G protein modulation to LCav2 which bears prominent 
voltage-independent G protein modulation, but not voltage-dependent one. The I-II linker and 
N-terminus chimeras were named L1R2L3L4 and R1L2L3L4 respectively, with the Arabic 
number symbols 1, 2, 3 and 4 representing the four repeated transmembrane domains, the 
letter L representing the cytoplasmic connecting regions from invertebrate LCav2 channel and 
the letter R representing the cytoplasmic connecting regions from mammalian rCav2.2 
channel. 
   
3.3.1 Construction of the LCav2 chimera with a mammalian I-II linker (L1R2L3L4) or 
mammalian N-terminus (R1L2L3L4) 
The chimeric LCav2 channels with the I-II linker (L1R2L3L4) or N-terminus (R1L2L3L4) 
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from rCav2.2 were constructed as followed (Figure 18): Step 1, a 2.5 kb MluI-NheI fragment 
from WTLCav2-IR-EGFP was cut and ligated into pGEMT (MluI/SpeI) to create mutagenesis 
shuttle vector, LCav2MSN-pGEMT (MluI-SpeI/NheI). For this cloning, NheI and SpeI were 
ligated together utilizing their compatible ends; Step 2, Silent restriction sites were 
constructed in LCav2 delimiting both ends of the I-II linker to facilitate the swapping of the 
I-II linker from rCav2.2 into LCav2MSN-pGEMT. At the 5’ end of the I-II linker was placed a 
BamHI restriction enzyme site and a SpeI restriction enzyme site was placed at the 3’ end. 
This included the alteration from GGATCG to GGATCC resulting in a silent mutation in a 
Serine base (TCG→TCC) and creating a BamHI restriction site. The alteration from 
ACTTGT to ACTAGT resulted in a silent mutation coding for a Leucine residue (CTT→CTA) 
and creating an SpeI restriction site. Swapping the N-terminus of rCav2.2 into 
LCav2MSN-pGEMT also involved creating unique restriction sites delimiting the 3’ end of 
the N-terminus. This included the alteration from TTC GAG to TTC GAA, resulting in a 
silent mutation in a Glutamic Acid base (GAG→GAA) and creating a unique SfuI 
(isochizomer BstBI) restriction site. SfuI (BstBI), BamHI, and SpeI sites were created by 
QuikChange Mutagenesis PCR (Forward, Primer 3#, Mega with Sfu1; Backward, Primer 4#, 
Mega with Sfu1 AS; Forward, Primer 5#, Mega with BamH1; Backward, Primer 6#, Mega 
with BamH1 AS; Forward, Primer 7#, Mega with Spe1; Backward, Primer 8#, Mega with 
Spe1 AS), resulting in mutant plasmids MSN-SfuI and MSN-BamHI-SpeI (Figure 19; Figure 
20). A MluI-HindIII fragment from MSN-SfuI, and HindIII-AvrII fragment from 
MSN-BamHI-SpeI were reinserted into LCav2MSN-pGEMT, to construct the shuttle vector 
LCav2SBS-pGEMT, which contained all three newly synthesized restriction sites, SfuI, 
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BamHI and SpeI (Figure 21); Step 3, the I-II linker from rCav2.2 was created with compatible 
5’ BamHI and 3’ SpeI restriction site ends in the PCR (Forward, Primer 9#, Ra1b BamH1f; 
Backward, Primer 10#, Ra1b Spe1b) using RatCav2.2-pMT2 containing the whole length 
rCav2.2 sequence in pMT2 vector as the template in the PCR. The I-II linker from rCav2.2 
was swapped in place of the I-II linker of LCav2 with BamHI and SpeI restriction enzymes 
into LCav2SBS-pGEMT, forming RatLinker-MSN; Step 4, The final LCav2 (L1R2L3L4) 
chimera (LCav2(Rat I-II linker)-IR-EGFP) was finished by swapping the mutagenized 
RatLinker-MSN clone into WTLCav2-IR-EGFP using MluI and BlpI restriction enzyme sites 
(Figure 22). 
The N-terminus of rCav2.2 was also cloned into the shuttle vector LCav2SBS-pGEMT. 
However, due to the high GC content and repeated sequences in this region, attempts to 
amplify the NT of rCav2.2 in the PCR failed several times, producing sequences with multiple 
deletions. A cloning strategy was applied using opportunistic restriction sites instead (Figure 
23). Generally, two steps were involved in creating the N terminus chimera: first, the N 
terminal region of rCav2.2 including a CMV promoter in the vector was cut from 
Ratα1b-pMT2 and inserted to the shuttle vector LCav2SBS-pGEMT resulting in the 
RatNT-MSN, where the N-terminus of LCav2 was interrupted and replaced. Then, the final 
N-terminus chimera LCav2(R1L2L3L4) (LCav2(RatNT)-IR-EGFP) was finished by swapping 
the mutagenized RatNT-MSN clone into WTLCav2-IR-EGFP using MluI and SalI restriction 
enzyme sites. This final plasmid was confirmed by double digestion (Figure 24). 
 
3.3.2 LCav2 (L1R2L3L4) and LCav2 (R1L2L3L4) chimeras lack the property of voltage 
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dependent G protein modulation 
4μg LCav2 (L1R2L3L4) or LCav2 (L1R2L3L4) chimera were cotransfected with 3μg rβ1 
(pMT2), 3μg rα2-δ (pMT2) and 1μg of rat G protein β1γ2 subunits into HEK293T cells and 
tested for relief of inhibition by G proteins using the paired-pulse facilitation protocol. It has 
been reported that the cytoplasmic I-II linker and N-terminus are necessary to confer 
voltage-dependent G protein modulation (De Waard et al., 1997), while our data suggested 
that the these two regions operating alone is not enough to confer the voltage dependent 
property to LCav2 channel. As illustrated in figure 25, under the endogenous G protein 
modulation from background G proteins in HEK cells, the PPF ratio value for LCav2 
(L1R2L3L4) was 0.94±0.01 (n=2); with the exogenous G protein modulation over the 
background, the PPF ratio values for LCav2 (L1R2L3L4) and LCav2 (L1R2L3L4) were also near 












Figure 17: Amino acids sequence alignment of N-terminus and I-II linker among rat Cav2 
family (rCav2.1, 2.2 and 2.3) and LCav2. Identical amino acids are in grey shadows while 
major discrepancies are in red boxes. Locations of the silent mutations are also indicated: a 
BamHI (GGATCC) site was designed in a Serine residue by an alteration from TCG to TCC; 
a SpeI (ACTAGT) site was designed in a Leucine residue by an alteration from CTT to CTA; 
and a SfuI (isochizomer BstBI) site was designed in a Glutamic Acid (TTC GAA) residue by 




















N Terminus Sequence Alignment 
I-II Linker Sequence Alignment:
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Figure 18: Illustration of Cloning Strategy to Construct LCav2 (L1R2L3L4) Chimera. Step 1, a 
2.5 kb MluI-NheI fragment from WTLCav2-IR-EGFP was cut and ligated into pGEMT 
(MluI/SpeI) to create mutagenesis shuttle vector, LCav2MSN-pGEMT (MluI-SpeI/NheI); Step 
2, Silent restriction sites BamHI, SpeI, and SfuI (isochizomer BstBI) were created into 
LCav2MSN-pGEMT; Step 3, The I-II linker from rCav2.2 was created in PCR and swapped 
into LCav2SBS-pGEMT, forming RatLinker-MSN; Step 4, The final LCav2 (L1R2L3L4) 
chimera (LCav2(Rat I-II linker)-IR-EGFP) was finished by swapping the mutagenized 
RatLinker-MSN clone into WTLCav2-IR-EGFP using MluI and BlpI restriction enzyme sites. 
Restriction enzyme sites chosen for cloning are colored blue and underlined. Inserted 
fragment for each ligation step is marked by a blue line. Silent restriction sites that were 






Figure 19: Restriction digestion analyses of three plasmid clones to identify successful SpeI 
mutants from QuikChange Mutagenesis PCR (Stratagene) to create SpeI restriction sites. 
Lane M is 1 kb plus DNA ladder, with 3 brightest bands of 5kb, 1.5kb and 500bp respectively. 
Lane 1, 3, 5 are undigested plasmids while lane 2, 4, 6 are their corresponding digestions by 
Spe1. Lane 5 and lane 6 represent the clone with the newly created SpeI site in the 
LCav2MSN-pGEMT shuttle plasmid, with a single digested band around 5.5kb by SpeI 












Figure 20: Double digestion to confirm the successful construction of MSN-SfuI, with a 
newly created SfuI (isochizomer BstBI) restriction site in the LCav2MSN-pGEMT shuttle 
plasmid. Lane M is 1 kb plus DNA ladder, with 3 brightest bands of 5kb, 1.5kb and 500bp 
respectively. Lane 1 is the double digestion by EcoRI and BstBI, with bands of expected sizes 
3029bp, 1354bp and 1114bp (indicated by star symbols) while the original 





















Figure 21: Double digestion to confirm the cloning of shuttle vector LCav2SBS-pGEMT. 
Lane M is 1kb DNA ladder; Lane1 is the uncut plasmid; Lane2 is the double digestion by 
BamHI/NotI displaying the expected sizes of 3805bp and 1689bp (indicated by star symbols); 
lane4 is the double digestion by BstbI/SpeI displaying the expected sizes of 4290bp and 












Figure 22: Double digestion to confirm the I-II linker chimera LCav2(L1R2L3L4). Lane M is 
1kb DNA ladder; lane1 and lane 3 are WTLCav2-IR-EGFP digested by SalI and SpeI 
respectively, which only owns one SalI site and one SpeI site (single bands are indicated by 
star symbols); lane2 and lane 4 are LCav2(L1R2L3L4) chimera digested by SalI or SpeI, which 
display 10991bp and 701bp pattern, and 7005bp and 4687bp pattern respectively (indicated 
by star symbols). Note that LCav2(L1R2L3L4) plasmid clone contains one extra SalI and SpeI 




















Figure 23: Illustration of Cloning Strategy to Construct LCav2(R1L2L3L4) Chimera. Step 1, the 
N terminal region of rCav2.2 was inserted to the shuttle vector LCav2SBS-pGEMT resulting 
in the RatNT-MSN; Step 2, the final N-terminus chimera LCav2(R1L2L3L4) 
(LCav2(RatNT)-IR-EGFP) was finished by swapping the mutagenized RatNT-MSN clone into 
WTLCav2-IR-EGFP using MluI and SalI restriction enzyme sites. Restriction enzyme sites 
chosen for cloning are colored blue and underlined. Inserted fragment for each ligation step is 
marked by a blue line. Silent restriction sites that were created are marked in red. This picture 












Figure 24: Double digestion to confirm the N-terminus chimera LCav2(R1L2L3L4). Lane M is 
1kb DNA ladder; Lane1 and lane 2 are the plasmid harboring chimera digested by BlpI and 
NdeI respectively, display 11005bp and 1610bp pattern, and 11838bp and 787bp pattern 
respectively (indicated by star symbols) while the WTLCav2-IR-EGFP bears only one BlpI 


























Figure 25: Histogram summarizing the paired-pulse facilitation experiment for I-II linker 
chimera LCav2(L1R2L3L4) and N-terminus chimera LCav2(R1L2L3L4). Columns are illustrated 
as mean values with SE error bars. The PPF ratios for LCav2(L1R2L3L4) with endogenous or 
exogenous mammalian G protein subunits expression are 0.94±0.01 and 0.90±0.04 
respectively. PPF ratio for LCav2(R1L2L3L4) with exogenous mammalian G protein subunits 
expression is 0.89±0.05. Numbers above indicate the amount of replicates. Note that PPF 
ratios are below unity for these two chimeras, indicating that the mammalian I-II linker or 


























Chapter 4 Discussion 
 G protein inhibition of presynaptic calcium channels is critical for suppressing synaptic 
transmission. The timing and strength of neurotransmitter release can be finely tuned through 
G protein coupled receptors (GPCR), but the detailed mechanism how calcium channels are 
modulated through the activation of G proteins is still poorly understood. In this MSc thesis, 
the structural requirement for voltage-dependent modulation of Cav2 channels is explored 
using an invertebrate presynaptic calcium channel LCav2. LCav2 does not share the same G 
protein modulation characteristics as rCav2.2, a mammalian homolog. Their differences serve 
as a basis for comparison in this study. 
 
4.1 G protein modulation of presynaptic Cav2 calcium channels 
Calcium ion entry through presynaptic Voltage Gated Calcium Channels (VGCC) is an 
essential step in neurotransmitter release. The Cav2 family of calcium channels include 
N-type (Cav2.2), P/Q-type (Cav2.1) and R-type (Cav2.3) channels. These different Cav2 genes 
are differentially distributed in presynaptic terminals, and vary in their inhibition by G 
proteins (Reid et al., 2003). G protein modulation through GPCRs such as GABA, adenosine 
A, dopamine and opioid receptors inhibit native calcium currents and reduce transmitter 
release, serving as an important means of adjusting presynaptic strength or preventing 
excessive transmission (Wu and Saggau, 1997). Although G protein modulation is present in 
both N-type and P/Q-type calcium channels, N-type channels display a stronger G protein 
inhibition than P/Q-type channels (Colecraft et al., 2000; Currie and Fox, 1997). Furthermore, 
different cell types express different quantities of N-type and P/Q-type calcium channels and 
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bear unique GPCR-coupled pathways for inhibiting calcium channels (Diverse-Pierluissi and 
Dunlap, 1993; Diverse-Pierluissi et al., 1995; Raingo et al., 2007; Shapiro and Hille, 1993). 
This greatly extends the capacity of G protein modulation in different cells. 
Voltage dependent inhibition is the predominant form of G protein modulation. The G 
protein effect is sensitive to membrane potential, with less pronounced inhibition at a more 
depolarized potential. Voltage-sensitive modulation is mediated through the direct coupling of 
Gβγ subunits, providing a direct, rapid and reversible modulatory effect. The voltage 
dependent modulation can be relieved by strong depolarizations and bursts of action potential 
waveforms (Brody et al., 1997). This provides an activity-dependent relief of inhibition 
adjusted by neuronal firing frequency (Ikeda and Dunlap, 2007). Voltage-sensitive inhibition 
varies considerably between N-type and P/Q-type currents in presynaptic terminals and their 
differences in G protein modulation may contribute to differences in short time plasticity in 
different synapses (Colecraft et al., 2000; Currie and Fox, 1997; Currie and Fox, 2002). 
A voltage independent G protein modulation has been identified in many preparations, 
which may utilize a distinct pathway (Diverse-Pierluissi et al., 1995; Raingo et al., 2007). 
Voltage independent modulation bears a slower onset and recovery rate, and provides a 
persistent inhibition independent of cellular activity. Voltage-dependent and independent 
components together diversify the possibilities for G protein modulation. 
 
4.2 Expression of invertebrate LCav2 channel 
Compared to multiple mammalian calcium channel isoforms, invertebrates including 
fruit fly (Drosophila melanogaster), Sea Hare (Aplysia californica) and nematode 
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(Caenorhabditis elegans) bear a single homolog representing multiple mammalian genes 
(Jeziorski et al., 2000). VGCC orthologs of Lymnaea stagnalis have been isolated, among 
which LCav2 is the representative of both mammalian N- and P/Q-type and responsible for 
neurotransmitter release (Spafford and Zamponi, 2003). In this research project, the LCav2 
channel was subcloned into a bicistronic expression vector pIRES2-EGFP and expressed in 
human embryonic kidney HEK293T cells (Figure 6, Figure 8). HEK293T cell line was 
chosen because its endogenous VGCC expression level was low and it was amenable for 
patch clamp recording.  
All recording were carried out at room temperature. It was suggested the recording 
temperature would affect channel activity. Increasing the temperature from 21oC to 37oC 
resulted in reduction in activation and inactivation time constant of T-type calcium channel 
(Iftinca et al., 2006). As snail belongs to poikilothermia animal, room temperature would 
better mimic the physiological environment of LCav2 calcium channel.  
Analyses of the current-voltage relationships indicated that LCav2 (n=7) and its rat 
homolog rCav2.2 (n=6) shared nearly identical voltage sensitivities under the same conditions 
(20mM extracellular barium). Both channels began to activate around -20mV and reached the 
peak value around +20mV (Figure 11). rCav2.2 peaked at +10mV in similar condition 
(Roullet et al., 1999), and perhaps the deviation observed in our experiments might reflect the 
endogenous G protein expression in our system evident from the larger prepulse facilitation 
ratios (See discussion below). On the other hand, results from another lab (Yasuda et al., 2004) 
also showed a similar Current-Voltage peak at +20mV for rCav2.2 under the same condition. 
The current-voltage curve for LCav2 was almost identical to previous experiments studying 
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LCav2 with the N-terminus from rCav2.1(Spafford et al., 2003a). As action potential waves 
begin at approximately -50mV and peak at +40mV, the activities of LCav2 and rCav2.2 would 
both greatly affected by neuron excitabilities. Similar voltage-sensitivies between invertebrate 
LCav2 and mammalian Cav2.2 channel may indicate conservation of the threshold and limits 
of voltage-dependent processes in neurons, such as synaptic transmission.  
 The time dependent inactivation decay and the voltage dependent inactivation decay of 
both channels were also compared (Figure 12, Figure 13). Barium was used as a charge 
replacing native calcium ion in the external solution to avoid activating calcium dependent 
processes, including potential calcium dependent inactivation of Cav2 channels. In 
comparison, the kinetics of inactivation decay of LCav2 at maximal current was significantly 
faster than that of rCav2.2. The fast component of inactivation decay was curve fit using a 
single exponential equation, with a tau value of 43.2±1.22ms for LCav2 and was 
130.6±0.85ms for rCav2.2. Typically, calcium channels have fast and slow components of 
inactivation decay, but only the fast component was determined here since the test pulse at 
peak current of +20mV was limited to 450ms, and not long enough to elaborate the other 
inactivating component. The faster inactivation decay might be a natural property of LCav2. 
One should consider that the calcium channels in HEK293T cells were evaluated at room 
temperature, (similar to the body temperature of snails) but much lower than the body 
temperature of mammals and the temperature of native rat channels (37oC). Perhaps, under 
native conditions, the inactivation decay of rCav2.2 might resemble the inactivation decay of 
LCav2 at room temperature. The kinetics of inactivation decay is also affected by the 
coexpression of Cavβ isoform, with highly variable results depending on which of four 
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mammalian beta subunits are expressed. A Lymnaea beta subunit of calcium channel LCavβ 
was shown to slow the kinetics of inactivation decay of LCav2 and rCav2.2 channels in vitro 
(Spafford et al., 2004) but multiple isoforms recently discovered in our lab may generate other 
possibilities for modulating inactivation properties (personal communication, Taylor 
Dawson).  
The voltage dependence of channel availability was measured using steady state 
conditions for inactivation. The half inactivation potential, where half of the channels were 
inactivated after a 4 second depolarization, was calculated as -39.8mV±0.82 for LCav2 and 
-49.6mV±1.45 for rCav2.2 (Figure 13). Both data were in accordance to previous reports 
(Roullet et al., 1999; Spafford et al., 2003a; Yasuda et al., 2004). However, with one replicate 
was conducted (n=1) each, more trials are suggested for statistic analysis. 
To summarize, although LCav2 and rCav2.2 channels shared biophysical similarities, 
there are some differences. While equally responding to activation, LCav2 showed a 
depolarizing shift in voltage dependent inactivation and much faster inactivation decay.   
  
4.3 LCav2 appears to lack voltage dependent G protein modulation 
A major feature of voltage dependent G protein modulation is that the inhibition of 
calcium channel activity could be relieved by a strong depolarization. PPF ratio measured by 
dividing the peak current with a prepulse to the peak current without a prepulse in the paired 
pulse facilitation protocol could be used to depict the extent of voltage dependent G protein 
inhibition. If the ratio is significantly above one, the voltage dependent G protein inhibition is 
present. The PPF ratio below or at one for the invertebrate LCav2 channel implied a lack of 
 96
apparent voltage-dependent G protein modulation (Figure 15). rCav2.2 had PPF ratios 
significantly above unity. The highest values was rCav2.2 with the coexpression of exogenous 
Gβ1γ2 subunits (1.95±0.11, n=8) compared to PPF ratio relying on lower endogenous G 
protein expression in HEK293T cells (1.37±0.07, n=9). The presence of exogenous 
Gβ1γ2 subunits was significant over endogenous background for evaluation of G protein 
modulation of rCav2.2 in a Turkey Test (at a 95% percent confidence level). PPF ratios were 
1.00±0.03 (n=8) and 0.95±0.03 (n=7) for LCav2 and were not significantly different with or 
without exogenous expression of G proteins respectively. 
 An interesting finding was that PPF ratios determined for LCav2 were sometimes below 
unity (Table 2). The lower than unity ratios have previously been attributed to a greater 
channel inactivation after a strong depolarizing prepulse, which is apparently masked during 
the G protein inhibition (Currie and Fox, 2002). 
Another key feature of channels undergoing voltage-dependent G protein modulation is a 
slowing of activation rate as the binding of Gβγ subunits retards the channel openings. 
Calcium channels would change from a “willing to open” mode to a “reluctant to open” mode 
when inhibited by G proteins, so that channel are not easily opened by small or moderate 
depolarizations (Bean, 1989). This is evident when comparing sample traces of facilitation (eg. 
Figure 14). Without a depolarizing prepulse, and thus under G protein inhibition, rCav2.2 
currents evaluated with coexpressed Gβ1γ2 subunits activated much more slowly compared 
to the current elicited after a strong depolarizing prepulse which temporarily relieved the G 
protein inhibition. Notice that LCav2 traces do not have altered slow activation kinetics under 
the same conditions. This is a one of the indicators besides PPF ratios that suggest an absence 
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of voltage dependent G protein modulation of LCav2 channels. In the future work, the role of 
Gβγ subunits could be confirmed by coexpressing β-ARK peptide which contains the Gβγ 
binding region of the β-Adrenergic Receptor Kinase (Tombler et al., 2006), and G protein 
modulation of LCav2 could also be explored by activating G protein coupled receptors such as 
mu-opiod receptor. 
One possibility for the absence of voltage-dependent G protein modulation is that 
invertebrate LCav2  might not be coupling to G protein subunits in vitro because they are 
mammalian instead of native snail ones. To explore this, an invertebrate Gβ subunit 
LGβ1 was isolated from Lymnaea stagnalis (cloned by MSc student, Taylor Dawson in the 
lab) and was coexpressed with calcium channel subunits and rat G protein gamma2 subunit. 
PPF ratios were determined electrophysiologically (Figure 16). The preliminary PPF ratio 
data gathered (1.02±0.117 (n=2)) indicated that LCav2 still lacked the voltage dependent G 
protein modulation property even with coexpressed Lymnaea G protein subunit, LGβ1. 
Perhaps this is not surprising, given that nifedipine-insensitive calcium currents in identified 
Lymnaea neurons (such as VD4) also lacked endogenous voltage-dependent G protein 
modulation (McCamphill et al. 2007 and Spafford, unpublished).  
A positive control using in vitro biochemistry and/or electrophysiological experiments 
will have to be performed to confirm that the in vitro expressed LGβ1 subunits form expressed 
proteins that will functionally interact with other proteins. For example, western blot might be 
performed to detect the expression of , and co-immunoprecipitation could be used to study the 
interaction between calcium channels and G beta subunit, while G protein-activated inwardly 
rectifying (GIRK) potassium channels, whose conductance would be enhanced by functional 
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Gβγ subunits, could serve as a surrogate that others have used to indicate functionality of in 
vitro expressed G proteins (Doering et al., 2004). 
Interestingly, when LGβ1 was coexpressed with rCav2.2, the PPF ratio was 1.33±0.1 
(n=3), and not significantly different from the endogenous mammalian G protein modulation 
in HEK293T cells. This suggests that LGβ1 did not functionally modulate rCav2.2 over the 
endogenous G protein background in HEK293T cells. If LGβ1 was well expressed in our 
system, it would be an unexpected finding that the invertebrate G protein beta subunit LGβ1 
also does not appear to be compatible with voltage-dependent G protein modulation in 
addition to the invertebrate Cav2 calcium channel. Previously, Arnot and colleagues 
demonstrated that different Gβ subunit genes have differing capacities for G protein 
facilitation of Cav2.2 channels. It was reported that Gβ5 was phylogenetically more distant 
from the other four G protein beta subunits (Gβ 1 to 4) and was unable to modulate N-type 
calcium channel (Arnot et al., 2000). A phylogenetic tree derived from amino acids sequence 
alignment (Figure 26 A) indicates that LGβ1 is closer to the calcium channel modulating G 
proteins (Gβ1-Gβ4) and more distant from the mammalian G protein subunit that does not 
interact with calcium channels, Gβ5. Although Gγ subunit might affect the function of Gβ, it 
was assumed it was Gβ that played a major role in G protein inhibition and exogenous 
expression work also indicated Gγ2 subunit could associate with most Gβ subunits (Arnot et 
al., 2000; Ruiz-Velasco and Ikeda, 2000; Zhou et al., 2000), indicating invertebrate LGβ 
should be able to associate mammalian rGγ2.Mutagenesis work by Doering and colleagues 
involved swapping regions between Gβ1 and Gβ5 to identify the critical residues in 
mammalian Gβ1 responsible for voltage dependent G protein modulation (Doering et al., 
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2004). Asn-110, Tyr-111, Val-112, residues 140-168 and 186-204 were considered important, 
and later, Tedford and colleagues suggested that Ser-189 was a particularly critical residue 
(Tedford et al., 2006). Comparisons between Lymnaea Gβ1 and equivalent mammalian G 
proteins using a sequence alignment (Figure 26 B) indicates that replacements of Gln156, 
Leu192 and Thr196 in rat G beta 1 subunit, which is greatly different from residues in the 
similar positions in LGβ, might cause the loss of binding/modulation property of LGβ1. These 
are three residues within the regions outlined by Doering and colleagues that were important 
for G protein modulation with rat G beta 1. Structural determinants for the possible absence of 
modulation of LGβ1  can be determined by future mutagenesis studies involving swapping 
residues in homologous positions like Thr196 into LGβ1 and assessing the possible gain of G 













Figure 26: Sequence alignment of invertebrate (Lymnaea) Gβ1 subunit and rat Gβ subunit 
homologs (rat Gβ 1-4). Panel A shows the phylogenetic tree based on amino acid sequences. 
Branch lengths represent probable evolutionary distance. Panel B illustrates the sequence 
alignment of G protein candidates for voltage dependent G protein modulation. The location 
of the last amino acid of each line is numbered. Dark and lighter grey-shaded amino acids 
represent identical and positive matches, respectively in the sequence alignment. Black boxes 
indicate the region of residues 110-112, residues 140-168 and residues 186-204 that have been 
described in previous studies to be critical for voltage-dependent G protein modulation of 
calcium channels. Amino acid residues within these outlined black boxes with little 
conservation in LGβ1 but are conserved in homologous mammalian G proteins are indicated 
in red. These three residues are Gln156, Leu192 and Thr196 in rGβ1 respectively. For future 
experiments, these three amino acids are excellent candidates for examination by site directed 













4.4 N-terminus and I-II linker of rCav2.2 alone did not confer voltage dependent G 
protein modulation to LCav2 calcium channels 
In previous reports, the N-terminus and I-II linker in mammalian Cav2 channel homologs 
were found to play a role in voltage-dependent G protein modulation (Agler et al., 2005; 
Bourinet et al., 1996; Zamponi et al., 1997). To identify the determinants for 
voltage-dependent G protein modulation, chimeras were constructed by swapping N-terminus 
and I-II linker from rCav2.2 into LCav2. Unique restriction sites were created using 
QuikChange Mutagenesis PCR, which served as a rapid method to introduce new restriction 
sites delimiting the regions to be swapped without changing the amino acid coding sequence. 
Both chimeras were successfully created and expressed. Interestingly, the chimeras with rat 
sequences, especially the N-terminal chimera LCav2 (R1L2L3L4) expressed better than the wild 
type LCav2 calcium channel. This was probably because the mammalian N-terminal sequence 
may have been more compatible with our mammalian expression system. Possibilities include 
that the N-terminal sequence may have increased the efficiency of transcription or translation 
or possibly the membrane targeting of LCav2 channels (Spafford et al., 2003a). 
The calculated PPF ratios indicated these two mammalian regions (i.e. the N-terminus 
and I-II linker) separately did not create a voltage dependent G protein modulation in the 
LCav2 calcium channel (Figure 25). Both the N-terminus or the I-II linker have been 
implicated as the G protein binding site by knock down or disruption of either of these two 
regions separately (De Waard et al., 1997; Zamponi et al., 1997). Our findings may be more 
consistent with the more recent work by Agler et al. proposing a cooperative interaction 
between N-terminus and I-II linker participating in Gβγ mediated voltage dependent 
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modulation (Agler et al., 2005). In future work, a double mutant with both N-terminus and 
I-II linker region from rCav2.2 in LCav2 will be constructed to address whether both domains 
participate cooperatively in voltage dependent G protein modulation. 
 
4.5 LCav2 as a model to study VD/VI G protein modulation 
Although the invertebrate LCav2 calcium channel lacks voltage dependent G protein 
modulation, recent work suggests that snail LCav2 currents can be depressed by G proteins. 
For example, when a constitutive-activator of G proteins GTP-γS, was included in the internal 
solution contained in the patch pipette, no LCav2 currents could be detected. Then when the 
same drug (GTP-γS) was dialyzed, LCav2 mediated barium currents were observed at first 
and then irreversibly ran down quickly and could not be relieved by repeated strong 
depolarizations (Spafford et al., 2003a). A similar G protein inhibition is apparent in cultured 
Lymnaea VD4 neurons. Patrick McCamphill (a PhD student in our lab) recently reported that 
application of serotonin to Lymnaea VD4 neurons inhibited presynaptic calcium currents by a 
mechanism that is sensitive to GDP-beta-S, an inhibitor of G protein activation. It is unlikely 
that this regulation is voltage-dependent, as the serotonin mediated inhibition in snails was 
likely mediated by the cytoplasmic second messenger pathway involving cAMP, and not a 
direct calcium channel inhibition from liberated G beta gamma subunits (McCamphill et al., 
2008). 
Interestingly, a possibly comparable voltage-insensitive G protein mechanism has been 
identified in mammals in pain sensory neurons of the dorsal root ganglia and sympathetic 
ganglia (Bernheim et al., 1991; Diverse-Pierluissi et al., 1995; Raingo et al., 2007). These 
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mechanisms in mammals appear to involve different G protein-mediated pathways, and 
different regions of calcium channels than the ubiquitous membrane-delimited, Gβγ mediated, 
voltage-dependent form of G protein modulation. It was proposed recently the tyrosine 1743 
and tyrosine 1747 in the C terminus of rCav2.2 were essential for voltage independent G 
protein modulation through a tyrosine kinase pathway (Raingo et al., 2007). Interestingly, 
both tyrosine residues are found in a similar position in the C terminus of LCav2. It is 
supposed the lack of necessary N-terminus/I-II linker interaction retarded the voltage 
dependent inhibition by Gβγ while we hypothesis that the conserved tyrosine residues in the 
C-terminus confers the ability of LCav2 to be modulated by Gα in a voltage-independent way. 
As LCav2 channel has an inherent voltage-independent G protein modulation, it will be 
interesting to address what is the consequence of heterologous expression of the chimeric 
presynaptic LCav2 channel with a voltage-dependent G protein modulatory site on the 
transmitter release modulation in invertebrate synapses.  Mammalian neurons contain a 
ubiquitous, voltage-dependent, G protein modulation, so only an invertebrate model provides 




In this project, an invertebrate voltage gated calcium channel (LCav2) isolated from the 
pond snail Lymnaea stagnalis was expressed in vitro and characterized. While it showed 
similar biophysical properties as its mammalian homolog rCav2.2 channel, LCav2 lacks the 
mammalian-type voltage dependent G protein modulation. Analyses of chimeric channels 
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indicated the N-terminus or I-II linker region from rCav2.2 alone was not enough to confer the 
voltage-dependent G protein modulation in LCav2. Furthermore, the Lymnaea G protein beta 




My research suggests that the voltage-dependent form of G protein modulation is not 
found in a representative invertebrate and thus may have arisen as a specialization in 
vertebrates. The potential more ancient voltage independent mechanism, is slower in onset 
and recovery, and is inhibitory without influence from cellular activity. Since the 
voltage-independent regulation appears to be amplified through the secondary messenger 
pathway, it is thus a highly-sensitive mechanism of inhibition requiring relatively low 
neurotransmitter concentration and receptor occupancy of the G protein coupled receptor to 
have a potent effect. 
In comparison, the voltage dependent G protein modulation is a dynamic and rapid form 
of calcium channel modulation that may alter synaptic strength. The rate and extent of 
inhibition of this form is proportional to the stimulus frequency. It also serves as a high pass 
filter, allowing only the strongest trains of action potentials to relieve inhibition and activate 
synaptic calcium channels. Vertebrates likely gained this voltage dependent G protein 
modulation during evolution to provide greater capacity for integration of nerve network 
signaling pathways. Having both voltage-dependent and voltage-independent modulation in 
the same cell diversifies the possibilities for modulation of synaptic activity. For example, the 
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voltage independent modulation is more enriched in nociceptive neurons to promote the 
possibilities for strong analgesic responses through opiate activation of G protein coupled 
receptors. In comparison, voltage dependent modulation might be involved in short-term 
activity dependent changes such as the laying down of short-term memory.  Voltage 
dependent modulation responds faster and self-adjusts more frequently and greatly extends 
the fine tuning ability in response to fluctuations in neural excitability. 
 
Future work: 
In future work, more chimeric channels will be made from rCav2.2 channels to create a 
voltage-dependent G protein modulation site in LCav2 channels to address its minimal 
structural requirements. The first step will be to assess whether the double mutant with both 
N-terminus and I-II linker regions from rCav2.2 will be enough to support voltage dependent 
G protein modulation. Future work may also include a closer examination of the endogenous 
voltage-independent G protein modulation of LCav2 channels by overexpression G protein 
coupled receptors (GPCRs) such as u-opioid receptor or dopamine receptor.  This in vitro 
work will be paired with neuronal work in identified presynaptic neurons and synapses to 








Appendix 1: List of primers 
 
Primer 1#, LCav2 Spe1f 5-GGA TCC CGG GTC AAC ACC AGT 
CAT CGT CAT CTT C-3 
Primer 2#, LCav2CT-Xma1 5-GCT CAC AGA ACT AGT GGC TAT 
CCA C-3 
Primer 3#, Mega with Sfu1 5-GAA TGG GGG CCA TTC GAA TAC 
ATG GTG CTA CTC AC-3 
Primer 4#, Mega with Sfu1 AS 5-GTG AGT AGC ACC ATG TAT TCG AAT 
GGC CCC CAT TC-3 
Primer 5#, Mega with BamH1 5-CAC TCA TCA TAC TGG GAT CCT TCT 
TCA TGC TAA ATC TAG-3 
Primer 6#, Mega with BamH1 AS 5-CTA GAT TTA GCA TGA AGA AGG ATC 
CCA GTA TGA TGA GTG-3 
Primer 7#, Mega with Spe1 5-GGT ACT CTA TAA GAC GAC TAG 
TGA AAA GCC AGC TTT-3 
Primer 8#, Mega with Spe1 AS 5-AGA AAA GCT GGC TTT TCA CTA 
GTC GTC TTA TAG AGT-3 
Primer 9#, Ra1b BamH1f 5-CAT TGG ATC CTT CTT CAT GCT CAA 
CCTG-3 















Appendix 2: List of original recording data 
 
Figure 9: This figure was generated from the recording: 07619005. 
Figure 10: This figure was generated from the recording 07611004. 
Figure 11: This figure was generated from the recordings of 07611004, 07619006, 07619013, 
07625013, 08211007, 08402015, 08507018 and 07617001, 07618006, 07621030, 08402003, 
08623006, 08623012. 
Figure 12: This figure was generated from the recordings of 07611003, 07619005, 07619012, 
07625010, 08205007, 08211005, 08402011, 08507016 and 07617000, 07621029, 08116002, 
08208001, 08402000, 08518007, 08623004, 08623010. 
Figure 13: This figure was generated from recordings 08508000 and 08623014. 
Figure 14: This figure was generated from recordings 07626007 and 07621041. 
Figure 15: This figure was generated based on recordings of: 07611005, 07619007, 07619014, 
07625011, 08205010, 08211006, 08402013, 08507017; 07626007, 07730005, 07730010, 
07811005, 07828001, 07831001, 07831013; 07617002, 07618004, 07621032, 08116001, 
08208003, 08402001, 08518005, 08623005, 08623011 and 07620002, 07621041, 07711004, 
07723001, 07812001, 08502003, 08602014, 08602022. 
Figure 16: This figure was generated from recordings 08304013, 08409028 and 08418003, 
08420004, 08415002. 
Figure 25: This figure was generated from recordings 08228011, 082280016; 08225003, 
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